These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 23573544)

  • 41. Apparent absence of atovaquone/proguanil resistance in 477 Plasmodium falciparum isolates from untreated French travellers.
    Musset L; Pradines B; Parzy D; Durand R; Bigot P; Le Bras J
    J Antimicrob Chemother; 2006 Jan; 57(1):110-5. PubMed ID: 16319183
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Multiresistant falciparum malaria cured using atovaquone and proguanil.
    Blanchard TJ; Mabey DC; Hunt-Cooke A; Edwards G; Hutchinson DB; Benjamin S; Chiodini PL
    Trans R Soc Trop Med Hyg; 1994; 88(6):693. PubMed ID: 7886775
    [No Abstract]   [Full Text] [Related]  

  • 43. Atovaquone-proguanil for treating uncomplicated Plasmodium falciparum malaria.
    Blanchard A; Hine P
    Emergencias; 2023 Apr; 35(2):139-141. PubMed ID: 37038945
    [No Abstract]   [Full Text] [Related]  

  • 44. Malaria diagnosis: still a challenge in non-endemic countries.
    Voulgaridi I; Koufakis T; Ntava E; Zisis N; Tsiakalou M
    Braz J Infect Dis; 2016; 20(4):410-1. PubMed ID: 27266590
    [No Abstract]   [Full Text] [Related]  

  • 45. Advanced Molecular Detection of Malarone Resistance.
    Talundzic E; Plucinski MM; Biliya S; Silva-Flannery LM; Arguin PM; Halsey ES; Barnwell JW; Vannberg F; Udhayakumar V
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3821-3. PubMed ID: 27001821
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical pharmacology of atovaquone and proguanil hydrochloride.
    Beerahee M
    J Travel Med; 1999 May; 6 Suppl 1():S13-7. PubMed ID: 23573547
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Atovaquone-proguanil chemoprophylaxis in the era of Tafenoquine.
    Meltzer E; Schwartz E
    J Travel Med; 2019 Jun; 26(4):. PubMed ID: 30535377
    [No Abstract]   [Full Text] [Related]  

  • 48. Cerebral malaria in spite of peripheral parasite clearance in a patient treated with atovaquone/proguanil.
    Koch S; Göbels K; Richter J; Oette M; Häussinger D
    Parasitol Res; 2007 Mar; 100(4):747-8. PubMed ID: 17004096
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Atovaquone/proguanil resistance in Africa: a case report.
    David KP; Alifrangis M; Salanti A; Vestergaard LS; Rønn A; Bygbjerg IB
    Scand J Infect Dis; 2003; 35(11-12):897-8. PubMed ID: 14723376
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Screening for mutations related to atovaquone/proguanil resistance in treatment failures and other imported isolates of Plasmodium falciparum in Europe.
    Wichmann O; Muehlberger N; Jelinek T; Alifrangis M; Peyerl-Hoffmann G; Muhlen M; Grobusch MP; Gascon J; Matteelli A; Laferl H; Bisoffi Z; Ehrhardt S; Cuadros J; Hatz C; Gjorup I; McWhinney P; Beran J; da Cunha S; Schulze M; Kollaritsch H; Kern P; Fry G; Richter J;
    J Infect Dis; 2004 Nov; 190(9):1541-6. PubMed ID: 15478057
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The safety of atovaquone-proguanil for the prevention and treatment of malaria in pregnancy: A systematic review.
    Andrejko KL; Mayer RC; Kovacs S; Slutsker E; Bartlett E; Tan KR; Gutman JR
    Travel Med Infect Dis; 2019; 27():20-26. PubMed ID: 30654041
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Atovaquone-proguanil in the treatment of imported uncomplicated Plasmodium falciparum malaria: a prospective observational study of 553 cases.
    Cordel H; Cailhol J; Matheron S; Bloch M; Godineau N; Consigny PH; Gros H; Campa P; Bourée P; Fain O; Ralaimazava P; Bouchaud O
    Malar J; 2013 Nov; 12():399. PubMed ID: 24200190
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Atovaquone-proguanil resistance in imported falciparum malaria in a young child.
    Rose GW; Suh KN; Kain KC; Le Saux N; McCarthy AE
    Pediatr Infect Dis J; 2008 Jun; 27(6):567-9. PubMed ID: 18434932
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment of uncomplicated multidrug-resistant falciparum malaria with artesunate-atovaquone-proguanil.
    van Vugt M; Leonardi E; Phaipun L; Slight T; Thway KL; McGready R; Brockman A; Villegas L; Looareesuwan S; White NJ; Nosten F
    Clin Infect Dis; 2002 Dec; 35(12):1498-504. PubMed ID: 12471569
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A Case report of atovaquone/proguanil induced esophageal ulcers.
    Carnino L; Hulo C; Puppa G; Konan DB; Chappuis F
    J Travel Med; 2020 Nov; 27(7):. PubMed ID: 33043369
    [No Abstract]   [Full Text] [Related]  

  • 56. Well-tolerated chemoprophylaxis uniformly prevented Swedish soldiers from Plasmodium falciparum malaria in Liberia, 2004-2006.
    Andersson H; Askling HH; Falck B; Rombo L
    Mil Med; 2008 Dec; 173(12):1194-8. PubMed ID: 19149338
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Erythema multiforme and Malarone(®).
    Becher G; Wylie G
    Travel Med Infect Dis; 2012 Sep; 10(5-6):279-80. PubMed ID: 22951669
    [No Abstract]   [Full Text] [Related]  

  • 58. An intricate case of multidrug resistant Plasmodium falciparum isolate imported from Cambodia.
    Dell'Acqua R; Fabrizio C; Di Gennaro F; Lo Caputo S; Saracino A; Menegon M; L'Episcopia M; Severini C; Monno L; Castelli F; Angarano G
    Malar J; 2017 Apr; 16(1):149. PubMed ID: 28410610
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antimalarial pharmacology and therapeutics of atovaquone.
    Nixon GL; Moss DM; Shone AE; Lalloo DG; Fisher N; O'Neill PM; Ward SA; Biagini GA
    J Antimicrob Chemother; 2013 May; 68(5):977-85. PubMed ID: 23292347
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A man with tropical travel history, fever, and pulmonary infiltrates.
    Wongba W; Ansari MJ; Okoli O; Garapati S; Iroegbu N; Spear JB
    Compr Ther; 2007; 33(1):21-4. PubMed ID: 17984489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.